Skip to content
Dose Brief
Menu
No. 250 here · Grade C

VyrarX review

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Visit VyrarX Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $329/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from VyrarX's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $179/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

VyrarX scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability75/100
Transparency72/100
Access Breadth50/100
Clinical Oversight89/100
Track Record73/100

What we like

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

The caveats

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

The brief

Best for: Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Ranked #250 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about VyrarX.

Closest here

The providers scoring nearest VyrarX — the realistic shortlist if you're weighing it.

Weighing VyrarX against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs VyrarX, and every provider that outranks it is listed on the VyrarX alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect VyrarX's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on VyrarX's site. Not medical advice; see our disclosure.

← Back to all rankings